Similar Outcomes For Minimally Invasive, Open Surgery In Colon Cancer
Large, open incisions that cause pain and require lengthy healing times might be unnecessary to treat colorectal cancer patients successfully.
|
Enterix Launches Test For Colorectal Cancer Screening
The availability of the CLIA-waived InSure Quik F I T test is intended to help physicians increase patient compliance with an annual colorectal cancer screening test.
|
GeneNews Reports Positive Results From Colorectal Cancer Study
GeneNews reported positive performance results from a large validation study of a six-gene biomarker panel for the assessment of a patient's current risk for colorectal cancer.
|
Non-Toxic Agents Added To Conventional Chemotherapy Decrease Survival Of Colon Cancer Cells
Adding curcumin or resveratrol to conventional chemotherapy could be effective in preventing the growth of chemo-resistant colon cancer cells.
|
Colon Cancer Screening Key To Prevention
Colon cancer screening is a tough sell.
|
Adults Above 50 Should Get Regular Colorectal Screenings
Colorectal cancer is a preventable disease, but more than 148,800 cases will be diagnosed in 2008 and an estimated 49,960 people will die from the disease.
|
Perioperative Eloxatin Regimen Reduced Risk Of Relapse In Colorectal Cancer Patients
In eligible patients Eloxatin in combination with 5-fluorouracil/leucovorin significantly improved three-year PFS compared to surgery alone when given perioperatively to colorectal cancer patients with initially resectable liver metastases.
|
Colorectal Cancer Screening Rates Increasing Among US Adults
The percentage of US adults aged 50 years and older getting screened for colorectal cancer is increasing.
|
Early Colon Cancer Detection Saves Lives
Early colon cancer detection is the key to its cure.
|
Colorectal Cancer Screening Recommendations Released
New colorectal cancer screening recommendations have been released and approved by health officials.
|
Expression Patterns of microRNAs Appear Altered in Colon Cancer
research has found an association between certain microRNA expression patterns and poor survival and treatment outcomes for colon cancer.
|
Novel Molecular Pattern Linked To Colon Cancer Prognosis
Research has identified a link between the expression patterns of a class of molecules called microRNAs and how a patient's colon cancer may progress.
|
Genomic Health Identifies Genes Associated With Colon Cancer Recurrence
Genomic Health announced results of studies that have identified genes that could help predict the likelihood of recurrence and chemotherapy benefit for early-stage colon cancer.
|
Nektar's Clinical Trial To Evaluate NKTR-102 Efficacy In Colorectal Cancer
Nektar Therapeutics starts Phase 2 clinical development program to evaluate NKTR-102 (PEG-irinotecan) as a potential treatment for colorectal cancer.
|
If You Are 50 And Over, Get Screened For Colorectal Cancer
ASGE encourages all men and women age 50 and over to add getting screened for colorectal cancer to their list of New Year's resolutions for 2008.
|
Many Medicare Beneficiaries Not Receiving Colorectal Cancer Screening
A new study finds significant underuse of colorectal cancer screening procedures among Medicare beneficiaries.
|
Studies confirm significant underuse of colorectal cancer screening
A majority of Americans who should be getting screened for colorectal cancer are not being screened for colon cancer.
|
ANAVEX 7-1037 Demonstrates Chemotherapeutic Potential For Treatment Of Colorectal Cancer
Anavex Life Sciences announced that ANAVEX 7-1037 has been shown to kill human HCT116 colon cancer cells in advanced pre-clinical studies.
|
Many Medicare beneficiaries not receiving colorectal cancer screening
The low overall colorectal cancer screening rates are consistent with previous studies, and that a majority of Medicare beneficiaries received incomplete or no colorectal cancer screening.
|
Quality Indicator For Colon Cancer Surgeries Questioned
Using the number of lymph nodes examined after colon cancer surgery, or colectomy, as a hospital quality indicator is gaining momentum.
|
CC Detect - Serum-Based Diagnostic Test For Colon Cancer Available
CC Detect, Panacea Pharmaceuticals's serum- based colon cancer diagnostic test, is now available from Panacea Laboratories.
|
Differences in cancer stage presentation between rural and urban patients
Urban colorectal and lung cancer patients present at later stages of disease than rural patients do.
|
Possible biomarker for colon cancer in people 50 and under
The finding may provide an early alert for younger patients with colon cancer and could prompt new research into colon cancer prevention and treatment strategies.
|
Personalized Interventions Improve Colon Cancer Screening Rates
One of the best ways to encourage an individual to get screened for colorectal cancer is to use a personalized approach.
|
FAQ When Considering Colorectal Cancer Screening Test
Results from two studies comparing colorectal cancer screening by conventional or optical colonoscopy versus CT colonography have sparked interest in colorectal cancer screening and may raise questions in the minds of consumers.
|
FDA Approves ERBITUX As A Single Agent In Patients With Advanced Colorectal Cancer
FDA has approved an update to the ERBITUX product labeling to include overall survival data as a single agent in epidermal growth factor inhibitor (EGFR)-expressing metastatic colorectal cancer patients.
|
Coronary Artery Disease Patients at Risk of Colon Cancer
Patients with coronary artery disease appear to have increased prevalence of colorectal tumors.
|
Avastin Curative Surgery Successful In Patients With Advanced Colorectal Cancer
High number of patients treated with Avastin plus standard chemotherapy for their colorectal cancer underwent complete surgical removal of their metastatic lesions.
|
Colorectal Cancer: A gene for metastasis
Weizmann Institute scientists reveal the actions of a key player in colorectal cancer.
|
Western Diet Linked To Risk Of Colon Cancer Recurrence
Colon cancer patients who eat a so-called "Western" diet may be increasing their chance of disease relapse and early death.
|
Compounds Coloring Fruits, Veggies May Protect Against Colon Cancer
Evidence from laboratory experiments on rats and on human colon cancer cells suggests that anthocyanins, the compounds that give color to most red, purple and blue fruits and vegetables appreciably slow the growth of colon cancer cells.
|
Colon Cancer A Disease Of Hormone Deficiency
Colon cancer is actually a disease of missing hormones that could potentially be treated by hormone replacement therapy.
|
YM BioSciences Initiates Patient Enrolment In Phase II Colorectal Cancer Trial
YM BioSciences has enrolled the first five patients in Phase II trial with nimotuzumab in combination with irinotecan for the treatment of patients with colorectal cancer.
|
NSAIDs treatment can reduce colorectal cancer risk
Safer drugs needed before regular preventive therapy for colon cancer can be recommended.
|
Colon Cancer Genetics Get Major Advance
Reporting on a 10-year study of colon cancer among Israeli Jews and Arabs the researchers discovered a genetic marker that increased a person's risk of colon cancer by 23 percent.
|
Encouraging Data From Study On New Blood Test For Colon Cancer
Study relates to two newly discovered blood proteins, CCSA-3 and CCSA-4 (Colon Cancer Specific Antigen 3 & 4) that could provide an additional tool to help clinicians determine the necessity and frequency of colonoscopy.
|
Additional 350,000 New Yorkers Have Been Screened For Colon Cancer
More New Yorkers are getting life-saving colonoscopies than ever before, and people of all races and incomes are benefiting.
|
Constab's New Tool To Treat Metastatic Colorectal, Other Cancers
Constab has further developed a drug candidate named Aimpila, that combines the Oncoshuttle platform with a direct apoptosis inducer capable of targeting and destroying cancer cells.
|
FOLFOX4 After Surgery Improves Overall Survival In Patients With Early Colon Cancer
FOLFOX4, an Eloxatin (oxaliplatin injection)-based chemotherapy regimen, significantly improved the overall survival of patients with surgically resected stage III colon cancer when compared to standard chemotherapy.
|
Free Colorectal Cancer Seminar Offered
Every four minutes someone in the United States is diagnosed with colorectal cancer, a diagnosis that can be overwhelming without appropriate information and support.
|
